Motor Cortex Stimulation for Parkinson's Disease
1 other identifier
interventional
13
1 country
1
Brief Summary
Deep Brain Stimulation represents the golden standard for surgical treatment of Parkinson disease (PD), but it is not optimally effective for controlling every motor sign and adverse events are not so infrequent Therefore, other approaches should be considered.We identified the motor cortex as a possible candidate and therefore we propose a double-blind randomized prospective study in 20 Parkinson patients in order:
- to test the efficacy of epidural motor cortex stimulation in Parkinson disease (primary endpoint: UPDRS III at 12 months at the end of the cross-over)
- to find out optimal electrode position and optimal stimulation parameters
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
March 10, 2008
CompletedFirst Posted
Study publicly available on registry
March 17, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedSeptember 2, 2015
September 1, 2015
5.5 years
March 10, 2008
September 1, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
UPDRS III
12 months - end of crossover
Secondary Outcomes (5)
UPDRS III
18, 30 and 31 months
UPDRS
6,12, 18, 30, 31 months
Parkinson's disease quality of life scale(PDQL)
6, 12, 18, 30, 31 months
Neuropsychological and mood evaluation
6, 12, 18, 30 months
Drug therapy
6, 12, 18, 30, 31 months
Study Arms (2)
A
EXPERIMENTALB
SHAM COMPARATORInterventions
The parameters of stimulation will be: contact 0 cathode, contact 3anode, 120microsec, 80 Hz, subthreshold for any movement or sensation, usually 3-5Volts. The stimulator will be switched on, continuously.
The parameters of stimulation will be: contact 0 cathode, contact 3 anode, 120microsec, 80 Hz, subthreshold for any movement or sensation, usually 3-5 volts. The stimulator will be switched off.
Eligibility Criteria
You may qualify if:
- Idiopathic PD as diagnosed by a neurologist - a movement disorders specialist, according to the Parkinson Disease Brain Bank criteria, with asymmetrical bradykinesia, rigidity, tremor and postural instability (at least 3 from the above)
- Significant clinical response to Levodopa (improvement of UPDRS motor score \> 20%).
- Disease duration \> 5 years
- Advanced stage of disease:
- UPDRS motor score in off condition \>/= 40/108
- Hoehn \& Yahr stage \>/= 3
- DBS surgery not indicated or expressly refused by the patient
- Antiparkinsonian therapy stable for at least one month prior to implant
- Capability to give informed consent to surgery and to the study.
You may not qualify if:
- Severe cognitive impairment or dementia
- Psychiatric disturbances with the exception of mild anxiety or depression and drug-induced psychiatric symptoms (i.e. benign hallucinations)
- History of epilepsy or documented electroencephalographic abnormalities suggesting epilepsy
- Previous neurosurgery of the brain (DBS or lesioning of the basal ganglia, fetal tissue transplantation )
- Lack of informed consent
- History of drug or alcohol abuse
- Poor general conditions increasing surgical risk or severe illness with poor prognosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Catholic University, Italylead
- Medtroniccollaborator
Study Sites (1)
Università Cattolica - Policlinico Gemelli - Neurochirurgia Funzionale
Roma, 00168, Italy
Related Publications (3)
Cioni B. Motor cortex stimulation for Parkinson's disease. Acta Neurochir Suppl. 2007;97(Pt 2):233-8. doi: 10.1007/978-3-211-33081-4_26.
PMID: 17691309BACKGROUNDPagni CA, Altibrandi MG, Bentivoglio A, Caruso G, Cioni B, Fiorella C, Insola A, Lavano A, Maina R, Mazzone P, Signorelli CD, Sturiale C, Valzania F, Zeme S, Zenga F. Extradural motor cortex stimulation (EMCS) for Parkinson's disease. History and first results by the study group of the Italian neurosurgical society. Acta Neurochir Suppl. 2005;93:113-9. doi: 10.1007/3-211-27577-0_19.
PMID: 15986739BACKGROUNDCioni B, Meglio M, Perotti V, De Bonis P, Montano N. Neurophysiological aspects of chronic motor cortex stimulation. Neurophysiol Clin. 2007 Dec;37(6):441-7. doi: 10.1016/j.neucli.2007.10.007. Epub 2007 Nov 1.
PMID: 18083500BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Beatrice Cioni, MD
Università Cattolica Roma, Italy
- STUDY CHAIR
Mario Meglio, Prof, MD
Università Cattolica Roma, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 10, 2008
First Posted
March 17, 2008
Study Start
December 1, 2007
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
September 2, 2015
Record last verified: 2015-09